Business / Finance

RSS

Electroanalysis journal publishes a special issue about clinical diagnostics

The demand for the development of novel diagnostic tools with interest for clinical analysis is increasing.

19 Jun 2014

Five Points Healthcare announces acquisition of BestCare Home Care

Five Points Healthcare announced that it acquired BestCare Home Care on April 30, 2014. BestCare is a home health provider of Medicare-certified, Medicaid-waiver and personal care services throughout Northern and Western Virginia.

18 Jun 2014

Medison to market uniQure's Glybera in Israel for treatment of lipoprotein lipase deficiency

uniQure N.V., a leader in human gene therapy, and Medison Pharma Ltd., Israel's leading international healthcare marketing group, today announced an exclusive distribution agreement under which Medison will market Glybera, uniQure's gene therapy product for the treatment of lipoprotein lipase deficiency (LPLD), in Israel and the Palestinian Authority.

18 Jun 2014

Janssen signs license agreement with Vertex to develop, commercialize VX-787 for influenza A treatment

Janssen Pharmaceuticals, Inc.announced today that it has entered into an exclusive license agreement with Vertex Pharmaceuticals for the worldwide development, manufacturing and commercialization of VX-787, a novel medicine in Phase II development for the treatment of influenza A.

18 Jun 2014

LABORIE completes acquisition of BUCK Elektromedizin and BUCKmeditec

Laborie Medical Technologies, Inc., based in Toronto, Ontario, has completed its acquisition of BUCK Elektromedizin GmbH and BUCKmeditec GmbH & Co. Bad Rappenaeau, Germany based BUCK develops and distributes innovative and advanced biofeedback and electrical stimulation equipment, accessories and consumables for pelvic floor dysfunction in the treatment of urinary and fecal incontinence.

18 Jun 2014

3SBio signs exclusive license agreement with Selecta Biosciences for pegsiticase

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with Selecta Biosciences for pegsiticase (Uricase PEG-20), a pegylated recombinant uricase from candida utilis.

18 Jun 2014

Western Oncolytics closes $275,000 in seed funding

Western Oncolytics Ltd., a biotech company specializing in immuno-oncolytic cancer therapies, has closed $275,000 in seed funding. The proceeds are planned to set a path toward clinical trials and execute initial manufacturing for its novel virus-based cancer therapy, which delivers genes to guide the immune system to kill cancer cells.

18 Jun 2014

Saint-Gobain Seals continues its long-standing relationship with OEMs

Saint-Gobain Seals continues its long-standing relationship with OEMs in the high-speed surgical drill market as their integral supplier of OmniSeal® spring-energized seals. The seals excel at protecting the sensitive internal components of the drill during surgery and sterilization, ensuring a long life of the tool.

17 Jun 2014

Distribution partnership announced by Nanion Technologies and Axion Biosystems

Nanion Technologies, a leading provider of automated patch clamp platforms, and Axion Biosystems, originator of the first high throughput microelectrode array system, today announce a distribution partnership in Europe and China. Nanion will immediately carry Axion’s MEA-products, supporting a broad range of biomedical applications.

17 Jun 2014

BioClinica announces acquisition of Blueprint Clinical to drive RBM strategies for clinical trials

BioClinica®, Inc., a leading provider of eClinical Solutions for the Pharmaceutical Industry, has announced the acquisition of Blueprint Clinical, a fast-growing company offering ground-breaking technology and extensive expertise to drive successful Risk-Based Monitoring (RBM) strategies for clinical trials.

From Clario 16 Jun 2014

Symbion and Surgery Partners sign definitive merger agreement

Surgery Center Holdings Inc. ("Surgery Partners" or "The Company"), a portfolio company of H.I.G. Capital, LLC ("H.I.G."), and Symbion Holdings Corporation ("Symbion"), a portfolio company of Crestview Partners, have announced that they have entered into a definitive merger agreement under which Surgery Partners will acquire 100% of the stock of Symbion for a total purchase price of $792 million.

16 Jun 2014

Arrowhead Research joins with broad-market Russell 3000 Index

Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, is set to join the broad-market Russell 3000 Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 27, according to a preliminary list of additions posted June 13 on www.russell.com/indexes.

16 Jun 2014

Pavilion Financial announces acquisition of the business of Plan Sponsor Advisors

Pavilion Financial Corporation, an employee-owned, diversified global investment services firm, today announced the acquisition of the business of Plan Sponsor Advisors, an investment and retirement benefit consulting firm specializing in defined contribution plans. The transaction is expected to close on or around June 20th.

12 Jun 2014

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Janssen R&D Ireland Ltd announced today that they have entered into a collaboration with ViiV Healthcare to develop and commercialize a new single tablet regimen containing Janssen's Non-Nucleoside Reverse Transcriptase Inhibitor rilpivirine (marketed as EDURANT®) and ViiV's Integrase Inhibitor dolutegravir(marketed as TIVICAY®) as the sole active ingredients for the maintenance treatment of people living with Human Immunodeficiency Virus (HIV).

12 Jun 2014

Hills Health to deploy Lincor's patient care technology in Australian and New Zealand hospitals

Lincor Solutions has secured an exclusive distribution agreement with Hills Health Solutions to deploy Lincor's next generation interactive patient care technology in Australian and New Zealand hospitals and aged care facilities for the first time.

11 Jun 2014

InSite and Senju collaborate to develop and market azithromycin ophthalmic solution using DuraSite

InSite Vision Incorporated and Senju Pharmaceutical Co., Ltd. today announced that they have entered into a collaboration and license agreement to develop and market InSite's azithromycin ophthalmic solution using DuraSite® including AzaSite® 1% and AzaSite XtraTM 2% ocular antibiotics in Japan. Senju has agreed to pay InSite an upfront license fee, additional development milestones fees, and a percentage royalty on net sales.

10 Jun 2014

Contacta to manufacture HLD large area hearing loop product platform in the USA

Contacta Inc. has today announced the HLD large area hearing loop product platform will be manufactured in the USA.

9 Jun 2014

Blue Sea Capital successfully closes debut fund with $327M of capital commitments

Blue Sea Capital LLC ("Blue Sea"), a private equity firm based in Palm Beach, Florida, and with an office in El Segundo, California, announced that it has successfully closed its debut fund with $327 million of capital commitments, of which approximately 10% comes from the General Partner and its affiliates.

9 Jun 2014

Stone Point Capital acquires LTCG

LTCG, the recognized leader in business process outsourcing for long-term care insurance, has been acquired by Stone Point Capital, a leading private equity firm focused on investing in the global financial services industry. This acquisition furthers Stone Point's strategy of backing innovative companies in the insurance and insurance services sectors.

9 Jun 2014

Seres Health closes $10 million Series B financing, signs research collaboration with Mayo Clinic

Seres Health, a clinical-stage therapeutics company developing novel products to treat a host of disease conditions based on scientific findings related to the human microbiome, announced today that it has closed its $10 million Series B financing that included existing investors Flagship Ventures and Enso Ventures, and included new investors, Mayo Clinic, Alexandria Venture Investments, and several private investors. The company has also entered into an exclusive research collaboration with the Mayo Clinic.

9 Jun 2014

Business / Finance

Electroanalysis journal publishes a special issue about clinical diagnostics

Five Points Healthcare announces acquisition of BestCare Home Care

Medison to market uniQure's Glybera in Israel for treatment of lipoprotein lipase deficiency

Janssen signs license agreement with Vertex to develop, commercialize VX-787 for influenza A treatment

LABORIE completes acquisition of BUCK Elektromedizin and BUCKmeditec

3SBio signs exclusive license agreement with Selecta Biosciences for pegsiticase

Western Oncolytics closes $275,000 in seed funding

Saint-Gobain Seals continues its long-standing relationship with OEMs

Distribution partnership announced by Nanion Technologies and Axion Biosystems

BioClinica announces acquisition of Blueprint Clinical to drive RBM strategies for clinical trials

Symbion and Surgery Partners sign definitive merger agreement

Arrowhead Research joins with broad-market Russell 3000 Index

Pavilion Financial announces acquisition of the business of Plan Sponsor Advisors

Janssen, Viiv Healthcare to develop single tablet regimen for maintenance treatment of HIV

Hills Health to deploy Lincor's patient care technology in Australian and New Zealand hospitals

InSite and Senju collaborate to develop and market azithromycin ophthalmic solution using DuraSite

Contacta to manufacture HLD large area hearing loop product platform in the USA

Blue Sea Capital successfully closes debut fund with $327M of capital commitments

Stone Point Capital acquires LTCG

Seres Health closes $10 million Series B financing, signs research collaboration with Mayo Clinic

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News